Taking the medications, eating a healthy diet, and incorporating physical activity into your lifestyle are all crucial steps to achieving results
Food and Drug Administration (FDA) recently announced full approval for the drug, selpercatinib (Retevmo), for treating patients ages 2 and older who have advanced cancer carrying a rare genetic change called RET fusion
If you are a new patient, please contact our new patient coordinator for appointment scheduling at [email protected] or (239) 649-7400 * As always, consult with your physician prior to making any substantial lifestyle, health or nutritional changes
Reconstituted peptide solutions are highly vulnerable to degradation from temperature fluctuations, light exposure, and contamination
Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients
Within each block of six consecutively-enrolled subjects, two subjects received placebo, two subjects received L-Carnitine, and two subjects received L-Carnitine-combination in a randomly-permuted order generated using www.randomization.com
